-
1
-
-
65249163311
-
The registry of the GerMAn competence NETwork on atrial fibrillation: Patient characteristics and initial MAnagement
-
Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P et al. The registry of the GerMAn competence NETwork on atrial fibrillation: patient characteristics and initial MAnagement. Europace 2009; 11: 423-434.
-
(2009)
Europace
, vol.11
, pp. 423-434
-
-
Nabauer, M.1
Gerth, A.2
Limbourg, T.3
Schneider, S.4
Oeff, M.5
Kirchhof, P.6
-
2
-
-
76849110820
-
The RecordAF study: Design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation
-
Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR et al. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol 2010; 105: 687-693.
-
(2010)
Am J Cardiol
, vol.105
, pp. 687-693
-
-
Le Heuzey, J.Y.1
Breithardt, G.2
Camm, J.3
Crijns, H.4
Dorian, P.5
Kowey, P.R.6
-
3
-
-
43049097195
-
International society of hypertension. Global burden of blood-pressure-related disease, 2001
-
Lawes CM, Vander Hoorn S, Rodgers A. International society of hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-1518.
-
(2008)
Lancet
, vol.371
, pp. 1513-1518
-
-
Lawes, C.M.1
Vander Hoorn, S.2
Rodgers, A.3
-
4
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm MAnagement and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
-
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm MAnagement and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
Selby, J.V.6
-
5
-
-
0032497292
-
Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
-
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
-
(1998)
Circulation
, vol.98
, pp. 946-952
-
-
Benjamin, E.J.1
Wolf, P.A.2
D'Agostino, R.B.3
Silbershatz, H.4
Kannel, W.B.5
Levy, D.6
-
6
-
-
0036797537
-
A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
-
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-364.
-
(2002)
Am J Med
, vol.113
, pp. 359-364
-
-
Stewart, S.1
Hart, C.L.2
Hole, D.J.3
McMurray, J.J.4
-
7
-
-
20044388522
-
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) study
-
Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 705-711.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 705-711
-
-
Wachtell, K.1
Hornestam, B.2
Lehto, M.3
Slotwiner, D.J.4
Gerdts, E.5
Olsen, M.H.6
-
8
-
-
0028299731
-
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study
-
Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
-
(1994)
JAMA
, vol.271
, pp. 840-844
-
-
Benjamin, E.J.1
Levy, D.2
Vaziri, S.M.3
D'Agostino, R.B.4
Belanger, A.J.5
Wolf, P.A.6
-
9
-
-
77957699729
-
Guidelines for the MAnagement of atrial fibrillation: The task force for the MAnagement of atrial fibrillation of the European Society of Cardiology (ESC)
-
European Heart Rhythm Association; European Association for Cardio-Thoracic
-
European Heart Rhythm Association; European Association for Cardio-Thoracic SurgeryCamm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the MAnagement of atrial fibrillation: the task force for the MAnagement of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Surgerycamm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
-
10
-
-
45849132016
-
Atrial fibrillation and isolated systolic hypertension: The systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study
-
Vagaonescu TD, Wilson AC, Kostis JB. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study. Hypertension 2008; 51: 1552-1556.
-
(2008)
Hypertension
, vol.51
, pp. 1552-1556
-
-
Vagaonescu, T.D.1
Wilson, A.C.2
Kostis, J.B.3
-
11
-
-
0346613575
-
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estiMAtes
-
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estiMAtes. Am J Cardiol 1998; 82: 2N-9N.
-
(1998)
Am J Cardiol
, vol.82
-
-
Kannel, W.B.1
Wolf, P.A.2
Benjamin, E.J.3
Levy, D.4
-
12
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm MAnagement and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
-
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm MAnagement and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
Selby, J.V.6
-
13
-
-
33747052359
-
Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
-
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
-
(2006)
Circulation
, vol.114
, pp. 119-125
-
-
Miyasaka, Y.1
Barnes, M.E.2
Gersh, B.J.3
Cha, S.S.4
Bailey, K.R.5
Abhayaratna, W.P.6
-
14
-
-
4844222283
-
Lifetime risk for development of atrial fibrillation: The Framingham Heart Study
-
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110: 1042-1046.
-
(2004)
Circulation
, vol.110
, pp. 1042-1046
-
-
Lloyd-Jones, D.M.1
Wang, T.J.2
Leip, E.P.3
Larson, M.G.4
Levy, D.5
Vasan, R.S.6
-
15
-
-
27944487524
-
A randomised controlled trial and cost-effectiveness study of systeMAtic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over the SAFE study
-
ix-x 1-74
-
Hobbs FD, FitzMUurice DA, Mant J, Murray E, Jowett S, Bryan S et al. A randomised controlled trial and cost-effectiveness study of systeMAtic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005; 9(40): iii-iiv, ix-x, 1-74.
-
(2005)
Health Technol Assess
, vol.9
, Issue.40
-
-
Hobbs, F.D.1
Fitzmaurice, D.A.2
Mant, J.3
Murray, E.4
Jowett, S.5
Bryan, S.6
-
16
-
-
0038777176
-
Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic target
-
Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003; 91: 9G-14G.
-
(2003)
Am J Cardiol
, vol.91
-
-
Healey, J.S.1
Connolly, S.J.2
-
17
-
-
79954917769
-
Absolute and attributable risks of atrial fibrillation in relation to optiMAl and borderline risk factors: The Atherosclerosis Risk in Communities (ARIC) study
-
Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, SoLiman EZ et al. Absolute and attributable risks of atrial fibrillation in relation to optiMAl and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 1501-1508.
-
(2011)
Circulation
, vol.123
, pp. 1501-1508
-
-
Huxley, R.R.1
Lopez, F.L.2
Folsom, A.R.3
Agarwal, S.K.4
Loehr, L.R.5
Soliman, E.Z.6
-
18
-
-
0030855939
-
Incidence of and risk factors for atrial fibrillation in older adults
-
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455.-2461.
-
(1997)
Circulation
, vol.96
, pp. 2455-2461
-
-
Psaty, B.M.1
Manolio, T.A.2
Kuller, L.H.3
Kronmal, R.A.4
Cushman, M.5
Fried, L.P.6
-
19
-
-
33847174197
-
Pulse pressure and risk of new-onset atrial fibrillation
-
Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007; 297: 709-715.
-
(2007)
JAMA
, vol.297
, pp. 709-715
-
-
Mitchell, G.F.1
Vasan, R.S.2
Keyes, M.J.3
Parise, H.4
Wang, T.J.5
Larson, M.G.6
-
20
-
-
66549087865
-
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women
-
Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119: 2146-2152.
-
(2009)
Circulation
, vol.119
, pp. 2146-2152
-
-
Conen, D.1
Tedrow, U.B.2
Koplan, B.A.3
Glynn, R.J.4
Buring, J.E.5
Albert, C.M.6
-
21
-
-
33847065906
-
Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts
-
Choisy SC, Arberry LA, Hancox JC, James AF. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 2007; 49: 498-505.
-
(2007)
Hypertension
, vol.49
, pp. 498-505
-
-
Choisy, S.C.1
Arberry, L.A.2
Hancox, J.C.3
James, A.F.4
-
22
-
-
33845659664
-
Atrial electrical and structural abnorMAlities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: Implications for development of atrial fibrillation
-
Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C et al. Atrial electrical and structural abnorMAlities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 2006; 27: 3045-3056.
-
(2006)
Eur Heart J
, vol.27
, pp. 3045-3056
-
-
Kistler, P.M.1
Sanders, P.2
Dodic, M.3
Spence, S.J.4
Samuel, C.S.5
Zhao, C.6
-
23
-
-
78751681578
-
Pathophysiological mechanisms of atrial fibrillation: A translational appraisal
-
Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011; 91: 265-325.
-
(2011)
Physiol Rev
, vol.91
, pp. 265-325
-
-
Schotten, U.1
Verheule, S.2
Kirchhof, P.3
Goette, A.4
-
24
-
-
0029033549
-
Influence of blood pressure on left atrial size. The Framingham Heart Study
-
Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension 1995; 25: 1155-1160.
-
(1995)
Hypertension
, vol.25
, pp. 1155-1160
-
-
Vaziri, S.M.1
Larson, M.G.2
Lauer, M.S.3
Benjamin, E.J.4
Levy, D.5
-
25
-
-
0037032224
-
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women
-
Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-1644.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1636-1644
-
-
Tsang, T.S.1
Gersh, B.J.2
Appleton, C.P.3
Tajik, A.J.4
Barnes, M.E.5
Bailey, K.R.6
-
26
-
-
0347063907
-
Risks for atrial fibrillation and congestive heart failure in patients 4/¼65 years of age with abnorMAl left ventricular diastolic relaxation
-
Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Risks for atrial fibrillation and congestive heart failure in patients 4/¼65 years of age with abnorMAl left ventricular diastolic relaxation. Am J Cardiol 2004; 93: 54-58.
-
(2004)
Am J Cardiol
, vol.93
, pp. 54-58
-
-
Tsang, T.S.1
Barnes, M.E.2
Gersh, B.J.3
Bailey, K.R.4
Seward, J.B.5
-
27
-
-
77951493485
-
Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysMAl atrial fibrillation
-
Toh N, Kanzaki H, Nakatani S, Ohara T, Kim J, Kusano KF et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysMAl atrial fibrillation. Hypertension 2010; 55: 1150-1156.
-
(2010)
Hypertension
, vol.55
, pp. 1150-1156
-
-
Toh, N.1
Kanzaki, H.2
Nakatani, S.3
Ohara, T.4
Kim, J.5
Kusano, K.F.6
-
28
-
-
77954350607
-
Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: Implications for the development of new atrial fibrillation
-
Okin PM, Gerdts E, Wachtell K, Oikarinen L, Nieminen MS, Dahlöf B et al. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. J Hypertens 2010; 28: 1534-1540.
-
(2010)
J Hypertens
, vol.28
, pp. 1534-1540
-
-
Okin, P.M.1
Gerdts, E.2
Wachtell, K.3
Oikarinen, L.4
Nieminen, M.S.5
Dahlöf, B.6
-
29
-
-
41949095907
-
Electrophysiological effects of angiotensin II. Part I: Signal transduction and basic electrophysiological mechanisms
-
Goette A, Lendeckel U. Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms. Europace 2008; 10: 238-241.
-
(2008)
Europace
, vol.10
, pp. 238-241
-
-
Goette, A.1
Lendeckel, U.2
-
30
-
-
79952217693
-
Upstream therapies for MAnagement of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: PriMAry prevention
-
Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for MAnagement of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: priMAry prevention. Europace 2011; 13: 308-328.
-
(2011)
Europace
, vol.13
, pp. 308-328
-
-
Savelieva, I.1
Kakouros, N.2
Kourliouros, A.3
Camm, A.J.4
-
31
-
-
0033919444
-
Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan
-
Shetty SS, DelGrande D. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. J PharMAcol Exp Ther 2000; 294: 179-186.
-
(2000)
J PharMAcol Exp Ther
, vol.294
, pp. 179-186
-
-
Shetty, S.S.1
Delgrande, D.2
-
32
-
-
33645236163
-
Role of angiotensin system and effects of its inhibition in atrial fibrillation: Clinical and experimental evidence
-
Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27: 512-518.
-
(2006)
Eur Heart J
, vol.27
, pp. 512-518
-
-
Ehrlich, J.R.1
Hohnloser, S.H.2
Nattel, S.3
-
33
-
-
0345688039
-
Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro
-
Izumi T, Kihara Y, Sarai N, Yoneda T, Iwanaga Y, Inagaki K et al. Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 2003; 108: 2530-2535.
-
(2003)
Circulation
, vol.108
, pp. 2530-2535
-
-
Izumi, T.1
Kihara, Y.2
Sarai, N.3
Yoneda, T.4
Iwanaga, Y.5
Inagaki, K.6
-
34
-
-
0037782347
-
Role of L-type calcium channels in pacing-induced short-term and long-term cardiac memory in canine heart
-
Plotnikov AN, Yu H, Geller JC, Gainullin RZ, Chandra P, Patberg KW et al. Role of L-type calcium channels in pacing-induced short-term and long-term cardiac memory in canine heart. Circulation 2003; 107: 2844-2849.
-
(2003)
Circulation
, vol.107
, pp. 2844-2849
-
-
Plotnikov, A.N.1
Yu, H.2
Geller, J.C.3
Gainullin, R.Z.4
Chandra, P.5
Patberg, K.W.6
-
35
-
-
0028278429
-
Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes
-
Daleau P, Turgeon J. Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes. Pflugers Arch 1994; 427: 553-555.
-
(1994)
Pflugers Arch
, vol.427
, pp. 553-555
-
-
Daleau, P.1
Turgeon, J.2
-
36
-
-
0019864795
-
Effects of angiotensin II on membrane current in cardiac Purkinje fibers
-
Kass RS, Blair ML. Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol 1981; 13: 797-809.
-
(1981)
J Mol Cell Cardiol
, vol.13
, pp. 797-809
-
-
Kass, R.S.1
Blair, M.L.2
-
37
-
-
34447536499
-
Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes
-
Saygili E, Rana OR, Saygili E, Reuter H, Frank K, Schwinger RH et al. Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes. Am J Physiol Heart Circ Physiol 2007; 292: H2898-H2905.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
-
-
Saygili, E.1
Rana, O.R.2
Saygili, E.3
Reuter, H.4
Frank, K.5
Schwinger, R.H.6
-
38
-
-
27744529917
-
Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation
-
Yamagishi S, Takenaka K, Inoue H. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation. Med Hypotheses 2006; 66: 118-120.
-
(2006)
Med Hypotheses
, vol.66
, pp. 118-120
-
-
Yamagishi, S.1
Takenaka, K.2
Inoue, H.3
-
39
-
-
33748662421
-
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
-
Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006; 296: 1242-1248.
-
(2006)
JAMA
, vol.296
, pp. 1242-1248
-
-
Okin, P.M.1
Wachtell, K.2
Devereux, R.B.3
Harris, K.E.4
Jern, S.5
Kjeldsen, S.E.6
-
40
-
-
77952795467
-
Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The life study
-
Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlö f B, Nieminen MS et al. Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Press 2010; 19: 169-175.
-
(2010)
Blood Press
, vol.19
, pp. 169-175
-
-
Wachtell, K.1
Gerdts, E.2
Aurigemma, G.P.3
Boman, K.4
Dahlö, F.B.5
Nieminen, M.S.6
-
41
-
-
34447632616
-
Prevalence of paroxysMAl atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension
-
Hennersdorf MG, Schueller PO, Steiner S, Strauer BE. Prevalence of paroxysMAl atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension. Hypertens Res 2007; 30: 535-540.
-
(2007)
Hypertens Res
, vol.30
, pp. 535-540
-
-
Hennersdorf, M.G.1
Schueller, P.O.2
Steiner, S.3
Strauer, B.E.4
-
42
-
-
0038642326
-
A meta-analysis of the effects of treatment on left ventricular MAss in essential hypertension
-
Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular MAss in essential hypertension. Am J Med 2003; 115: 41-46.
-
(2003)
Am J Med
, vol.115
, pp. 41-46
-
-
Klingbeil, A.U.1
Schneider, M.2
Martus, P.3
Messerli, F.H.4
Schmieder, R.E.5
-
43
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
-
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611-616.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
Lanke, J.4
Hedner, T.5
Niklason, A.6
-
44
-
-
0033589756
-
Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
-
Hansson L, Lindholm LH, Ekbom T, Dahlö f B, Lanke J, Scherstén B et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-1756.
-
(1999)
Lancet
, vol.354
, pp. 1751-1756
-
-
Hansson, L.1
Lindholm, L.H.2
Ekbom, T.3
Dahlö, F.B.4
Lanke, J.5
Scherstén, B.6
-
45
-
-
71849109250
-
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
-
Haywood LJ, Ford CE, Crow RS, Davis BR, MAssie BM, Einhorn PT et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol 2009; 54: 2023-2031.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2023-2031
-
-
Haywood, L.J.1
Ford, C.E.2
Crow, R.S.3
Davis, B.R.4
Massie, B.M.5
Einhorn, P.T.6
-
46
-
-
3242762366
-
Angiotensinconverting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation
-
L'Allier PL, Ducharme A, Keller PF, Yu H, Guertin MC, Tardif JC. Angiotensinconverting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J AmColl Cardiol 2004; 44: 159-164.
-
(2004)
J AmColl Cardiol
, vol.44
, pp. 159-164
-
-
L'Allier, P.L.1
Ducharme, A.2
Keller, P.F.3
Yu, H.4
Guertin, M.C.5
Tardif, J.C.6
-
47
-
-
20044369896
-
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) study
-
Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712-719.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 712-719
-
-
Wachtell, K.1
Lehto, M.2
Gerdts, E.3
Olsen, M.H.4
Hornestam, B.5
Dahlöf, B.6
-
48
-
-
39849093283
-
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: The VALUE trial
-
Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens 2008; 26: 403-411.
-
(2008)
J Hypertens
, vol.26
, pp. 403-411
-
-
Schmieder, R.E.1
Kjeldsen, S.E.2
Julius, S.3
McInnes, G.T.4
Zanchetti, A.5
Hua, T.A.6
-
49
-
-
74949142925
-
Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: A nested case-control study
-
Schaer BA, Schneider C, Jick SS, Conen D, Osswald S, Meier CR. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Ann Intern Med 2010; 152: 78-84.
-
(2010)
Ann Intern Med
, vol.152
, pp. 78-84
-
-
Schaer, B.A.1
Schneider, C.2
Jick, S.S.3
Conen, D.4
Osswald, S.5
Meier, C.R.6
-
50
-
-
77952129062
-
Prevention of atrial fibrillation by renin-angiotensin system inhibition a metaanalysis
-
Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by renin-angiotensin system inhibition a metaanalysis. J Am Coll Cardiol 2010; 55: 2299-2307.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2299-2307
-
-
Schneider, M.P.1
Hua, T.A.2
Bohm, M.3
Wachtell, K.4
Kjeldsen, S.E.5
Schmieder, R.E.6
-
51
-
-
10744221998
-
Use of enalapril to facilitate sinus rhythm MAintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study
-
Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC et al. Use of enalapril to facilitate sinus rhythm MAintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003; 24: 2090-2098.
-
(2003)
Eur Heart J
, vol.24
, pp. 2090-2098
-
-
Ueng, K.C.1
Tsai, T.P.2
Yu, W.C.3
Tsai, C.F.4
Lin, M.C.5
Chan, K.C.6
-
52
-
-
0037118662
-
Use of irbesartan to MAintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study
-
MAdrid AH, Bueno MG, Rebollo JM, MAr?́n I, Peñ a G, Bernal E et al. Use of irbesartan to MAintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002; 106: 331-336.
-
(2002)
Circulation
, vol.106
, pp. 331-336
-
-
Madrid, A.H.1
Bueno, M.G.2
Rebollo, J.M.3
Maŕn, I.4
Peñ, A.G.5
Bernal, E.6
-
53
-
-
13144297790
-
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation
-
Van Noord T, Crijns HJ, van den Berg MP, Van Veldhuisen DJ, Van Gelder IC. Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation. BMC Cardiovasc Disord 2005; 5: 3.
-
(2005)
BMC Cardiovasc Disord
, vol.5
, pp. 3
-
-
Van Noord, T.1
Crijns, H.J.2
Van Den Berg, M.P.3
Van Veldhuisen, D.J.4
Van Gelder, I.C.5
-
54
-
-
34347349119
-
Candesartan in the prevention of relapsing atrial fibrillation
-
Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P. Candesartan in the prevention of relapsing atrial fibrillation. Int J Cardiol 2007; 120: 85-91.
-
(2007)
Int J Cardiol
, vol.120
, pp. 85-91
-
-
Tveit, A.1
Seljeflot, I.2
Grundvold, I.3
Abdelnoor, M.4
Arnesen, H.5
Smith, P.6
-
55
-
-
64749085587
-
Valsartan for prevention of recurrent atrial fibrillation
-
GISSI-AF Investigators
-
GISSI-AF InvestigatorsDisertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L et al. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 2009; 360: 1606-1617.
-
(2009)
N Engl J Med
, vol.360
, pp. 1606-1617
-
-
Disertori, M.1
Latini, R.2
Barlera, S.3
Franzosi, M.G.4
Staszewsky, L.5
-
56
-
-
33646680763
-
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients
-
Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E et al. Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc PharMAcol 2006; 47: 46-50.
-
(2006)
J Cardiovasc PharMAcol
, vol.47
, pp. 46-50
-
-
Fogari, R.1
Mugellini, A.2
Destro, M.3
Corradi, L.4
Zoppi, A.5
Fogari, E.6
-
57
-
-
41349084427
-
Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus
-
Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P et al. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. J Cardiovasc PharMAcol 2008; 51: 217-222.
-
(2008)
J Cardiovasc PharMAcol
, vol.51
, pp. 217-222
-
-
Fogari, R.1
Zoppi, A.2
Mugellini, A.3
Corradi, L.4
Lazzari, P.5
Preti, P.6
-
58
-
-
50249084425
-
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptoMAtic lone atrial fibrillation
-
Fogari R, Derosa G, Ferrari I, Corradi L, Zoppi A, Lazzari P et al. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptoMAtic lone atrial fibrillation. Am J Hypertens 2008; 21: 1034-1039.
-
(2008)
Am J Hypertens
, vol.21
, pp. 1034-1039
-
-
Fogari, R.1
Derosa, G.2
Ferrari, I.3
Corradi, L.4
Zoppi, A.5
Lazzari, P.6
-
59
-
-
33748087086
-
Prospective randomized study comparing amiodarone vs amiodarone plus losartan vs amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysMAl atrial fibrillation
-
Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X et al. Prospective randomized study comparing amiodarone vs amiodarone plus losartan vs amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysMAl atrial fibrillation. Eur Heart J 2006; 27: 1841-1846.
-
(2006)
Eur Heart J
, vol.27
, pp. 1841-1846
-
-
Yin, Y.1
Dalal, D.2
Liu, Z.3
Wu, J.4
Liu, D.5
Lan, X.6
-
60
-
-
77951481204
-
Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptoMAtic paroxysMAl atrial fibrillation
-
KoMAtsu T, Tachibana H, Sato Y, Ozawa M, Kunugida F, Nakamura M. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptoMAtic paroxysMAl atrial fibrillation. Int Heart J 2010; 51: 98-104.
-
(2010)
Int Heart J
, vol.51
, pp. 98-104
-
-
Komatsu, T.1
Tachibana, H.2
Sato, Y.3
Ozawa, M.4
Kunugida, F.5
Nakamura, M.6
-
61
-
-
54049140455
-
CTAF Investigators. Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: Insights from the Canadian Trial of Atrial Fibrillation (CTAF)
-
Palardy M, Ducharme A, Nattel S, Tardif JC, White M, Racine N et al. CTAF Investigators. Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). Can J Cardiol 2008; 24: 709-713.
-
(2008)
Can J Cardiol
, vol.24
, pp. 709-713
-
-
Palardy, M.1
Ducharme, A.2
Nattel, S.3
Tardif, J.C.4
White, M.5
Racine, N.6
-
62
-
-
79953776126
-
Randomized trial of angiotensin II-receptor blocker vs dihydropiridine calcium channel blocker in the treatment of paroxysMAl atrial fibrillation with hypertension II (J-RHYTHM Study)
-
YaMAshita T, Inoue H, Okumura K, KodaMA I, Aizawa Y, Atarashi H et al. Randomized trial of angiotensin II-receptor blocker vs dihydropiridine calcium channel blocker in the treatment of paroxysMAl atrial fibrillation with hypertension II (J-RHYTHM Study). Europace 2011; 13: 473-479.
-
(2011)
Europace
, vol.13
, pp. 473-479
-
-
Yamashita, T.1
Inoue, H.2
Okumura, K.3
Kodama, I.4
Aizawa, Y.5
Atarashi, H.6
-
64
-
-
79952398794
-
Irbesartan in patients with atrial fibrillation
-
ACTIVE I Investigators
-
ACTIVE I InvestigatorsYusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M et al. Irbesartan in patients with atrial fibrillation. N Engl J Med 2011; 364: 928-938.
-
(2011)
N Engl J Med
, vol.364
, pp. 928-938
-
-
Yusuf, S.1
Healey, J.S.2
Pogue, J.3
Chrolavicius, S.4
Flather, M.5
-
65
-
-
78650951581
-
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
-
Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. J Thromb Haemost 2011; 9: 39-48.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 39-48
-
-
Van Staa, T.P.1
Setakis, E.2
Di Tanna, G.L.3
Lane, D.A.4
Lip, G.Y.5
-
66
-
-
79956341734
-
ACP journal club. CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillation
-
Cairns JA. ACP journal club. CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillation. Ann Intern Med 2011; 154: JC5-JC13.
-
(2011)
Ann Intern Med
, vol.154
-
-
Cairns, J.A.1
-
67
-
-
0033899856
-
Analysis of risk factors involved in oral-anticoagulantrelated intracranial haemorrhages
-
Berwaerts J, Webster J. Analysis of risk factors involved in oral-anticoagulantrelated intracranial haemorrhages. QJM 2000; 93: 513-521.
-
(2000)
QJM
, vol.93
, pp. 513-521
-
-
Berwaerts, J.1
Webster, J.2
-
68
-
-
33947307931
-
Effect of hypertension on anticoagulated patients with atrial fibrillation
-
Lip GY, Frison L, Grind M. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 2007; 28: 752-759.
-
(2007)
Eur Heart J
, vol.28
, pp. 752-759
-
-
Lip, G.Y.1
Frison, L.2
Grind, M.3
-
69
-
-
79954982790
-
Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension
-
Ho LY, Siu CW, Yue WS, Lau CP, Lip GY, Tse HF. Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension. J Hum Hypertens 2011; 25: 304-310.
-
(2011)
J Hum Hypertens
, vol.25
, pp. 304-310
-
-
Ho, L.Y.1
Siu, C.W.2
Yue, W.S.3
Lau, C.P.4
Lip, G.Y.5
Tse, H.F.6
-
71
-
-
79953304900
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Rate and rhythm MAnagement
-
Gillis AM, VerMA A, Talajic M, Nattel S, Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm MAnagement. Can J Cardiol 2011; 27: 47-59.
-
(2011)
Can J Cardiol
, vol.27
, pp. 47-59
-
-
Gillis, A.M.1
Verma, A.2
Talajic, M.3
Nattel, S.4
Dorian, P.5
-
72
-
-
78650901054
-
2011 ACCF/AHA/HRS focused update on the MAnagement of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes 3rd NA et al. 2011 ACCF/AHA/HRS focused update on the MAnagement of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 57: 223-242.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 223-242
-
-
Wann, L.S.1
Curtis, A.B.2
January, C.T.3
Ellenbogen, K.A.4
Lowe, J.E.5
Estes III, N.A.6
-
73
-
-
55949133149
-
Changes in home versus clinic blood pressure with antihypertensive treatments: A meta-analysis
-
Ishikawa J, Carroll DJ, Kuruvilla S, Schwartz JE, Pickering TG. Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension 2008; 52: 856-864.
-
(2008)
Hypertension
, vol.52
, pp. 856-864
-
-
Ishikawa, J.1
Carroll, D.J.2
Kuruvilla, S.3
Schwartz, J.E.4
Pickering, T.G.5
-
74
-
-
79959670994
-
Measuring blood pressure for decision MAking and quality reporting: Where and how MAny measures?
-
Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision MAking and quality reporting: where and how MAny measures? Ann Intern Med 2011; 154: 781-788.
-
(2011)
Ann Intern Med
, vol.154
, pp. 781-788
-
-
Powers, B.J.1
Olsen, M.K.2
Smith, V.A.3
Woolson, R.F.4
Bosworth, H.B.5
Oddone, E.Z.6
-
75
-
-
77956399308
-
Blood pressure variability and risk of new-onset atrial fibrillation: A systeMAtic review of randomized trials of antihypertensive drugs
-
Webb AJ, Rothwell PM. Blood pressure variability and risk of new-onset atrial fibrillation: a systeMAtic review of randomized trials of antihypertensive drugs. Stroke 2010; 41: 2091-2093.
-
(2010)
Stroke
, vol.41
, pp. 2091-2093
-
-
Webb, A.J.1
Rothwell, P.M.2
-
76
-
-
77749245884
-
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
-
Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-948.
-
(2010)
Lancet
, vol.375
, pp. 938-948
-
-
Rothwell, P.M.1
|